Osiris study boosts prospects of wound product, stock doubles
(Reuters) - Osiris Therapeutics Inc said data from a study showed that its Grafix wound-care product proved "overwhelmingly" effective in treating dia...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/-mhzwbSpCI0/story01.htm
No comments:
Post a Comment